Fig. 1 · Structure
Documents & Downloads
Dipivefrin hydrochloride
Antiglaucoma Prodrug
Dipivefrin hydrochloride is an antiglaucoma prodrug that is hydrolyzed to epinephrine by esterases in the cornea. This conversion plays a crucial role in decreasing intraocular pressure by enhancing aqueous humor outflow and reducing aqueous humor production. Dipivefrin hydrochloride is primarily utilized in the research of glaucoma treatment and the pharmacological mechanisms of adrenergic agents. Its efficacy in ocular therapeutics makes it a valuable compound for ophthalmic research applications.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 64019-93-8 |
| Applications | Antiglaucoma Prodrug |
| Formula | C19H30ClNO5 |
| Molecular Weight | 387.90 |
| Synonyms | Dipivefrine hydrochloride |
| SMILES | CNCC(C1=CC=C(OC(C(C)(C)C)=O)C(OC(C(C)(C)C)=O)=C1)O.[H]Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.